pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,140 catalysts · 3,045 8k filing · 572 earnings · 172 phase 2 completion · 169 grant · 133 drug shortage · 121 approval

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 16 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 8 catalysts2026-11-03: 17 catalysts2026-11-04: 22 catalysts2026-11-05: 36 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-04-08×clear all
type
  • 8k filing3,045
  • earnings572
  • phase 2 completion172
  • grant169
  • drug shortage133
  • approval121
phase 1 completion
73
  • phase 2 initiation62
  • device 510k54
  • recall51
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Apr 6, 2026

    50
    ›Apr 8, 2026grant125d agoSRI INTERNATIONAL — Development and Support of the Pathway Tools SoftwareSRI International

    AI grant. $1,219,508. PI: PETER D KARP

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoUNIV OF NORTH CAROLINA CHAPEL HILL — MASTL Kinase in DNA Repair and Treatment Resistance in Oral Squamous Cell Car...

    DE grant. $42,358. PI: Odjo Gouttia

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoUNIVERSITY OF TX MD ANDERSON CAN CTR — Proline tRNA biogenesis as oncogenic drivers and therapeutic target in T cell...

    CA grant. $473,372. PI: Palaniraja Thandapani

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoHEALTHPARTNERS INSTITUTE — Data-driven Development of Clinically Translatable EHR-Based Models to Estima...

    MH grant. $199,747. PI: Kathleen Miley

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoFRED HUTCHINSON CANCER CENTER — Investigating the impact of type I IFN signaling on regulatory T cell functio...

    AI grant. $49,343. PI: Lakshmi S Warrier

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoSTANFORD UNIVERSITY — Advancing iPSC-derived Thymic Epithelial Cells as Cell Therapy for T Cell Imm...Stanford University

    AI grant. $809,250. PI: Katja Gabriele Weinacht

    full page →nih reporter ↗
    ›Apr 8, 2026grant125d agoUT SOUTHWESTERN MEDICAL CENTER — Mentoring in Translational Research in Inflammatory Skin Disease

    AR grant. $123,108. PI: Tamia Alisha Harris-Tryon

    full page →nih reporter ↗
    ›Apr 9, 2026approval124d agoMULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — FDA approvalMULTIPLE VITAMINS INJECTION ADULT

    Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS

    full page →MULTIPLE VITAMINS INJECTION ADULT →fda approvals ↗
    ›Apr 9, 2026approval124d agoVABYSMO (FARICIMAB-SVOA) — FDA approvalfaricimab

    Sponsor: GENENTECH INC. Form: INJECTABLE. Route: INTRAVITREAL

    full page →faricimab →fda approvals ↗
    ›Apr 9, 2026approval124d agoFOSFOMYCIN TROMETHAMINE — FDA approvalFOSFOMYCIN TROMETHAMINE

    Sponsor: AUCTA. Form: FOR SOLUTION. Route: ORAL

    full page →FOSFOMYCIN TROMETHAMINE →fda approvals ↗
    ›Apr 9, 2026approval124d agoDILTIAZEM HYDROCHLORIDE — FDA approvalBausch Health US LLC

    Sponsor: ACTAVIS LABS FL INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval124d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval124d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval124d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval124d agoDOXYCYCLINE HYCLATE — FDA approvalPolyPid Ltd.

    Sponsor: IMPAX LABS INC. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval124d agoDEFLAZACORT — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: UPSHER SMITH LABS. Form: SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval124d agoDULOXETINE HYDROCHLORIDE — FDA approvalduloxetine hydrochloride DR

    Sponsor: ALEMBIC. Form: CAPSULE, DELAYED REL PELLETS. Route: ORAL

    full page →duloxetine hydrochloride DR →fda approvals ↗
    ›Apr 9, 2026approval124d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Apr 9, 2026approval124d agoLAMOTRIGINE — FDA approvalLAMOTRIGINE

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →LAMOTRIGINE →fda approvals ↗
    ›Apr 9, 2026approval124d agoMESNA — FDA approvalMESNA

    Sponsor: RISING. Form: INJECTABLE. Route: INTRAVENOUS

    full page →MESNA →fda approvals ↗
    ›Apr 9, 2026approval124d agoONUREG (AZACITIDINE) — FDA approvalBristol-Myers Squibb Co

    Sponsor: BRISTOL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval124d agoLEVETIRACETAM — FDA approvalAprecia Pharmaceuticals LLC

    Sponsor: CHARTWELL RX. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval124d agoCOSOPT PF (DORZOLAMIDE HYDROCHLORIDE) — FDA approvalCosopt

    Sponsor: THEA PHARMA. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Cosopt →fda approvals ↗
    ›Apr 9, 2026approval124d agoLAMOTRIGINE — FDA approvalTorrent Pharma Inc

    Sponsor: UNICHEM LABS LTD. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Apr 9, 2026approval124d agoREZENOPY (NALOXONE HYDROCHLORIDE) — FDA approvalnaloxone hydrochloride

    Sponsor: SCIENTURE. Form: SPRAY. Route: NASAL

    full page →naloxone hydrochloride →fda approvals ↗
    ›Apr 9, 2026approval124d agoMULTIPLE VITAMINS INJECTION ADULT (ALPHA-TOCOPHEROL ACETATE) — FDA approvalMULTIPLE VITAMINS INJECTION ADULT

    Sponsor: APOTEX. Form: SOLUTION. Route: INTRAVENOUS

    full page →MULTIPLE VITAMINS INJECTION ADULT →fda approvals ↗
    ›Apr 9, 2026approval124d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Apr 9, 2026approval124d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Apr 9, 2026approval124d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Apr 9, 2026approval124d agoDOXYCYCLINE HYCLATE — FDA approvalDOXYCYCLINE HYCLATE

    Sponsor: RISING. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →DOXYCYCLINE HYCLATE →fda approvals ↗
    ›Apr 9, 2026device 510k124d agoRay Co., Ltd. — RCT800 (510k cleared)Ray Therapeutics Inc

    Product code: OAS. Advisory committee: Radiology. Type: Special

    full page →fda device 510k ↗
    ›Apr 9, 2026device 510k124d agoCheckcells, Inc. — Seaman Pro/Seaman (510k cleared)

    Product code: POV. Advisory committee: Hematology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 9, 2026device 510k124d agoInternational Life Sciences — Artelon Convenience Kits (510k cleared)

    Product code: QWJ. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 9, 2026device 510k124d agoZest Anchors, LLC — LOCATOR® Angled Abutment (510k cleared)

    Product code: NHA. Advisory committee: Dental. Type: Special

    full page →fda device 510k ↗
    ›Apr 9, 2026device 510k124d agoCG Bio Co., Ltd. — EASYMADE-TI (510k cleared)3H Bio Co Ltd

    Product code: GXN. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 9, 2026device 510k124d agoMaduro Medical, Inc. — Radical 6F Access Catheter (510k cleared)

    Product code: QJP. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Apr 9, 2026device 510k124d agoKLISBio S.r.l. — SILKBridge (510k cleared)

    Product code: JXI. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 9, 2026device 510k124d agoSpineart SA — SPINEART Navigation Instrument System (510k cleared)

    Product code: OLO. Advisory committee: Neurology. Type: Special

    full page →fda device 510k ↗
    ›Apr 9, 2026device 510k124d agoShanghai Apolo Medical Technology Co., Ltd. — Picosecond Nd:YAG Laser Systems (Model: HS-298) (510k cleared)NewBay Medical Technology Co Ltd

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 9, 2026device 510k124d agoAnhui Happiness Workshop Instruments Co., Ltd. — Single Use Digital Flexible Ureteroscope (7.5F); Videoscope Imaging Processor (Model HV-200) (510k cleared)

    Product code: FGB. Advisory committee: Gastroenterology, Urology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 9, 2026device 510k124d agoShandong Huge Dental Material Corporation — Eternal Art Porcelain Powders (510k cleared)

    Product code: EIH. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 9, 2026device 510k124d agoRivanna Medical, Inc. — Accuro XV (510k cleared)Vivani Medical, Inc.

    Product code: IYO. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Apr 9, 2026device pma124d agoSynergy Spine Solutions, Inc. — Synergy Disc (PMA supplement)

    Supplement type: Normal 180 Day Track No User Fee. Product code: MJO. Advisory committee: OR. Decision: APPR

    full page →fda device pma ↗
    ›Apr 9, 2026device pma124d agoAsahi Kasei Medical Co., Ltd. — Plasmaflo OP-05 W(A) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MDP. Advisory committee: GU. Decision: OK30

    full page →fda device pma ↗
    ›Apr 9, 2026device pma124d agoW. L. Gore & Associates, Inc. — GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: QZK. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Apr 9, 2026device pma124d agoMedtronic, Inc. — Avalus Bioprosthesis (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: LWR. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Apr 9, 2026device pma124d agoEv3 Neurovascular — Apollo™ Onyx™ Delivery Micro Catheter (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MFE. Advisory committee: NE. Decision: OK30

    full page →fda device pma ↗
    ›Apr 9, 2026device pma124d agoAdvanced Bionics — HiResolution™ Bionic Ear System Ultra and Ultra 3D Thin PCB (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MCM. Advisory committee: EN. Decision: OK30

    full page →fda device pma ↗
    ›Apr 9, 2026device pma124d agoNovocure, GmbH — Optune HFE Transducer Array Soft Part Components (PMA supplement)NovoCure Ltd

    Supplement type: 30-Day Notice. Product code: NZK. Advisory committee: NE. Decision: OK30

    full page →fda device pma ↗
    ›Apr 9, 2026device pma124d agoCooperVision, Inc. — Biofinity Sphere, Biofinity XR Sphere, Biofinity Energys, Biofinity Toric, Biofinity XR Toric, Biofinity Multifocal; Bio (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30

    full page →fda device pma ↗
    ← prev
    page 2 of 83
    next →
    $AMRX17.88-1.43%
    $SCNX0.3314-4.08%
    $VANI1.6000+18.52%
    $PYPD4.7700-1.45%
    $NVCR20.05+28.74%
    $MDT89.41+2.58%
    $PYPD4.7700-1.45%
    $PYPD4.7700-1.45%
    $PYPD4.7700-1.45%